Tesa M. Severson

Employment

• Antoni van Leeuwenhoek Netherlands Cancer Institute Research Area Psychosocial Research and Epidemiology Associate Staff Scientist
  2022 - Present

Education

• Universiteit Utrecht PhD

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Enhancer plasticity in endometrial tumorigenesis demarcates non-coding somatic mutations and 3D-genome alterations boosting the oncogenic driver ESR1
  2023 DOI: 10.1101/2023.07.25.550368
  +Save
• Data from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.c.6549566
  +Save
• Data from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.c.6549566.v1
  +Save
• Supplementary Data from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.22541195.v1
  +Save
• Supplementary Data from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.22541195
  +Save
• Supplementary Figure from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.22541192.v1
  +Save
• Supplementary Figure from Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  2023 DOI: 10.1158/2159-8290.22541192
  +Save
• Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence
  Cancer Discovery 2022 DOI: 10.1158/2159-8290.CD-21-0576
  +Save
• The MSP‐RON axis stimulates cancer cell growth in models of triple negative breast cancer
  Molecular Oncology 2020 DOI: 10.1002/1878-0261.12734
  +Save
• The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer
  2020 DOI: 10.1101/2020.02.19.956508
  +Save
• Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
  OncoImmunology 2018 DOI: 10.1080/2162402X.2018.1509820
  +Save